306 related articles for article (PubMed ID: 19423265)
1. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
Baratti D; Kusamura S; Deraco M
Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
[No Abstract] [Full Text] [Related]
2. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Yano H; Moran BJ; Cecil TD; Murphy EM
Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
[TBL] [Abstract][Full Text] [Related]
3. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR
J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
5. Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Baratti D; Kusamura S; Martinetti A; Seregni E; Oliva DG; Laterza B; Deraco M
Ann Surg Oncol; 2007 Feb; 14(2):500-8. PubMed ID: 17151789
[TBL] [Abstract][Full Text] [Related]
6. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
Sugarbaker PH
Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799
[No Abstract] [Full Text] [Related]
7. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*.
Yan TD; Deraco M; Elias D; Glehen O; Levine EA; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH;
Cancer; 2011 May; 117(9):1855-63. PubMed ID: 21509762
[TBL] [Abstract][Full Text] [Related]
8. Results of treatment of 33 patients with peritoneal mesothelioma.
Sebbag G; Yan H; Shmookler BM; Chang D; Sugarbaker PH
Br J Surg; 2000 Nov; 87(11):1587-93. PubMed ID: 11091251
[TBL] [Abstract][Full Text] [Related]
9. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
Yan TD; Yoo D; Sugarbaker PH
Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
[TBL] [Abstract][Full Text] [Related]
10. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
[TBL] [Abstract][Full Text] [Related]
11. Malignant peritoneal mesothelioma.
Bani-Hani KE; Gharaibeh KA
J Surg Oncol; 2005 Jul; 91(1):17-25. PubMed ID: 15999348
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive management of diffuse malignant peritoneal mesothelioma.
Sugarbaker PH; Yan TD; Stuart OA; Yoo D
Eur J Surg Oncol; 2006 Aug; 32(6):686-91. PubMed ID: 16621431
[TBL] [Abstract][Full Text] [Related]
13. [Prolonged survival in peritoneal mesotheliomas. Apropos of a case].
Berthet B; Guieu C; Blanc AP; Palayodan A; Chamlian A; Assadourian R
Ann Chir; 1995; 49(1):76-7. PubMed ID: 7741473
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):327-37. PubMed ID: 26210689
[No Abstract] [Full Text] [Related]
15. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.
Saxena A; Chua TC
Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416
[No Abstract] [Full Text] [Related]
16. [Short-term intraperitoneal infusion of cisplatin and OK-432 for a case of malignant mesothelioma of the peritoneum].
Kuwabara K; Ishida H; Ohsawa T; Nakata H; Murata N; Hashimoto D; Adachi A; Itoyama S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2333-5. PubMed ID: 12484067
[TBL] [Abstract][Full Text] [Related]
17. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Sugarbaker PH
J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
[No Abstract] [Full Text] [Related]
18. [A case of malignant peritoneal mesothelioma with a good response to treatment].
Mihara N; Hachisuga T; Yamasaki S; Fukuda K; Iwasaka G; Sugimori H; Miyahara S
Gan No Rinsho; 1987 Dec; 33(15):1939-44. PubMed ID: 3430746
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
[TBL] [Abstract][Full Text] [Related]
20. [Malignant peritoneal mesothelioma].
Wambach G; Weller P; Pietsch M; Kaufmann W
Dtsch Med Wochenschr; 1986 Mar; 111(13):517-8. PubMed ID: 3956396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
